Search results for “Translational Inhibition” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 29 patents, we discovered top 11 key players by total patent application. Monsanto Technology LLC, eFFECTOR Therapeutics Operations, Inc., Ionis Pharmaceuticals, Inc. are dominant in this area. They take 51.72% of the total patent filing.
Monsanto Technology LLC
Missouri, United States
Patent: 7
eFFECTOR Therapeutics Operations, Inc.
California, United States
Patent: 4
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 4
Yoshindo, Inc.
Okinawa-ken, Japan
Patent: 2
Yeasen Biotechnology (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 2
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 1
Rigel Pharmaceuticals, Inc.
California, United States
Patent: 1
GlaxoSmithKline Biologicals SA
Belgium
Patent: 1
Galapagos Genomics NV
Belgium
Patent: 1
STARTUP
Shenzhen Chi-Biotech Co. Ltd.
Guangdong Sheng, China
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Shenzhen Chi-Biotech Co. Ltd.
Guangdong Sheng, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 18 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing eFFECTOR Therapeutics Operations, Inc., Yeasen Biotechnology (Shanghai) Co., Ltd., Boston University take 44.44% of patent filing during this period.
eFFECTOR Therapeutics Operations, Inc.
California, United States
Patent: 4
Yeasen Biotechnology (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 2
Boston University
Massachusetts, United States
Patent: 2
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 2
Monsanto Technology LLC
Missouri, United States
Patent: 2
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 2
STARTUP
Shenzhen Chi-Biotech Co. Ltd.
Guangdong Sheng, China
Patent: 1
Univ of Pittsburgh
United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 18 patents in last 5 years, we discover 5 new entrants. eFFECTOR Therapeutics Operations, Inc., Yeasen Biotechnology (Shanghai) Co., Ltd., Boston University are the most active new entrants in this area.
eFFECTOR Therapeutics Operations, Inc.
California, United States
Patent: 4
Yeasen Biotechnology (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 2
Boston University
Massachusetts, United States
Patent: 2
STARTUP
Shenzhen Chi-Biotech Co. Ltd.
Guangdong Sheng, China
Patent: 1
Univ of Pittsburgh
United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 31 patents, we discovered top 11 universities and scientific research institutions by total patent application. Icahn School of Medicine at Mount Sinai, Boston University, Osaka University are dominant in this area. They take 48.39% of the total patent filing.
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 4
Boston University
Massachusetts, United States
Patent: 2
Osaka University
Osaka-fu, Japan
Patent: 2
Nara Institute Of Science & Technology
Nara-ken, Japan
Patent: 2
Yale University
Connecticut, United States
Patent: 1
Cornell University
New York, United States
Patent: 1
McGill University
Ontario, Canada
Patent: 1
Kyoto University
Kyoto-fu, Japan
Patent: 1
Peking University
Beijing Shi, China
Patent: 1
Nanjing Agricultural University
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: